[go: up one dir, main page]

ITFI20050083A1 - USE OF KINURENIC ACID FOR THE PREVENTION AND TREATMENT OF SHOCK - Google Patents

USE OF KINURENIC ACID FOR THE PREVENTION AND TREATMENT OF SHOCK

Info

Publication number
ITFI20050083A1
ITFI20050083A1 IT000083A ITFI20050083A ITFI20050083A1 IT FI20050083 A1 ITFI20050083 A1 IT FI20050083A1 IT 000083 A IT000083 A IT 000083A IT FI20050083 A ITFI20050083 A IT FI20050083A IT FI20050083 A1 ITFI20050083 A1 IT FI20050083A1
Authority
IT
Italy
Prior art keywords
shock
prevention
treatment
kinurenic acid
kinurenic
Prior art date
Application number
IT000083A
Other languages
Italian (it)
Inventor
Andrea Cozzi
Flavio Moroni
Original Assignee
Univ Firenze
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Firenze filed Critical Univ Firenze
Priority to IT000083A priority Critical patent/ITFI20050083A1/en
Priority to PCT/IB2006/001059 priority patent/WO2006117624A2/en
Publication of ITFI20050083A1 publication Critical patent/ITFI20050083A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT000083A 2005-04-29 2005-04-29 USE OF KINURENIC ACID FOR THE PREVENTION AND TREATMENT OF SHOCK ITFI20050083A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT000083A ITFI20050083A1 (en) 2005-04-29 2005-04-29 USE OF KINURENIC ACID FOR THE PREVENTION AND TREATMENT OF SHOCK
PCT/IB2006/001059 WO2006117624A2 (en) 2005-04-29 2006-04-28 Kynurenic acid and salts thereof for the prevention and treatment of shock

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000083A ITFI20050083A1 (en) 2005-04-29 2005-04-29 USE OF KINURENIC ACID FOR THE PREVENTION AND TREATMENT OF SHOCK

Publications (1)

Publication Number Publication Date
ITFI20050083A1 true ITFI20050083A1 (en) 2006-10-30

Family

ID=37307232

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000083A ITFI20050083A1 (en) 2005-04-29 2005-04-29 USE OF KINURENIC ACID FOR THE PREVENTION AND TREATMENT OF SHOCK

Country Status (2)

Country Link
IT (1) ITFI20050083A1 (en)
WO (1) WO2006117624A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3055548B1 (en) * 2016-09-05 2018-09-28 Metabrain Research USE OF METABOLITES OF TRYPTOPHAN IN THE TREATMENT OF MUSCLE ATROPHY
PL234411B1 (en) 2017-01-20 2020-02-28 Milart Pawel Improved formula of preparations for oral and enteral nutrition of children

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988007851A1 (en) * 1987-04-06 1988-10-20 Innovative Therapeutics Corporation Liposome entrapped n-methyl-d-aspartate receptor blockers
US5039528A (en) * 1989-12-11 1991-08-13 Olney John W EAA antagonists as anti-emetic drugs
DE69224069T2 (en) * 1991-09-09 1998-07-02 Warner-Lambert Co., Ann Arbor, Mich. PHARMACEUTICAL COMBINATION PRODUCT CONTAINING A URICOSURIC AGENT AND AN EXCITATORIC AMINO ACID ANTAGONIST

Also Published As

Publication number Publication date
WO2006117624A3 (en) 2007-03-01
WO2006117624A2 (en) 2006-11-09

Similar Documents

Publication Publication Date Title
MA28802B1 (en) THERAPEUTIC USES OF RTP801 INHIBITORS
CY2016035I2 (en) THERAPEUTIC USE OF ANTI-CS1 ANTIBODIES
IL180371A0 (en) Method of treating sjogren's syndrome
CY2015025I1 (en) METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE
BRPI0312331A2 (en) hyaluronic acid compositions and methods of use.
EP1968937A4 (en) DIAZAPURIN ANALOGUES OF 1'-AZA-L-NUCLEOSIDES
ZA200706868B (en) 4-Oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine diseases
IL183827A0 (en) Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders
ITMI20050262A1 (en) SUBSTANCES COMPOSITIONS AND METHODS OF TREATMENT OF ALOPECIA
CY2013031I1 (en) USE OF DIHYDROIMIDAZOLONES FOR THE TREATMENT OF EPILEPSY IN DOGS
ITMI20031311A0 (en) FORMULATIONS FOR THE TREATMENT OF ARTHROTIC DISORDERS
GB0307671D0 (en) Improvements relating to the construction of playing surfaces
NO20033803L (en) Carbamate compounds for use in the prevention or therapy of movement disorders
DE602004026081D1 (en) THERAPEUTIC HUMANIZED ANTIBODIES TO CD45 ISOFORMS
DE60326190D1 (en) of the body
ITTO20050715A1 (en) FOOTWEAR FOR PREVENTION AND CORRECTION OF THE VALGO ALLUCE
ITFI20050041A1 (en) HYDROXAMMED AS INHIBITORS OF ISTONE DEACELITASIS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS THAT CONTAIN THEM
EP1765331A4 (en) Methods and compositions for the treatment of pulmonary diseases
SI1831227T1 (en) Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders
ITFI20050083A1 (en) USE OF KINURENIC ACID FOR THE PREVENTION AND TREATMENT OF SHOCK
EP1740221A4 (en) Methods and compositions for the treatment of polycystic diseases
FI20040180L (en) Composition for the treatment of psoriasis
ITMI20042139A1 (en) PROCEDURE FOR THE PRODUCTION OF CEFEPIME AND CEFAPOSPORINE ANALOGHE
GB2396117B (en) Improvements relating to the construction of playing surfaces
ITSV20050039A1 (en) FLEXIBLE EYEWEAR AND PROCEDURE FOR THE REALIZATION OF THE SAME